文献速递呼吸衰竭与机械通气重症综合管理与镇静镇痛

中性粒细胞与淋巴细胞比值与急性呼吸窘迫综合征患者死亡率之间的关联:一项回顾性队列研究

The Association Between the Neutrophil-to-Lymphocyte Ratio and Mortality in Patients With Acute Respiratory Distress Syndrome: A Retrospective Cohort Study.
PubMed 文献 · Shock · 2019-01-01
一句话结论在ICU的ARDS患者中,较高NLR与28天死亡率升高相关,NLR似乎可作为预后生物标志物。

这项回顾性队列研究纳入224例ICU的ARDS患者,按NLR四分位数分为四组,评估NLR与28天死亡率的关系。四组NLR中位数分别为6.88、13.06、20.99、39.39,28天死亡率分别为10.7%、19.6%、41.4%、53.6%(P<0.001)。多变量Cox回归显示,以第一四分位为参照,第三四分位调整HR=5.075(95%CI 1.554-16.576,P=0.007),第四四分位调整HR=5.815(95%CI 1.824-18.533,P=0.003),第二四分位HR=1.674(95%CI 0.462-6.063,P=0.432)。ICU死亡率和住院死亡率呈相似趋势。作者认为NLR似乎是ARDS危重患者预后的生物标志物,需前瞻性数据进一步验证。

要点

  • 在224例ICU的ARDS患者中,NLR最高四分位组(中位数39.39)28天死亡率为53.6%,最低四分位组(中位数6.88)为10.7%(P<0.001)。
  • 多变量Cox回归中,以第一四分位为参照,第三四分位调整HR=5.075(95%CI 1.554-16.576,P=0.007),第四四分位调整HR=5.815(95%CI 1.824-18.533,P=0.003)。
  • 第二四分位与第一四分位相比,调整HR=1.674(95%CI 0.462-6.063,P=0.432),未达统计学显著。
  • ICU死亡率和住院死亡率呈现与28天死亡率相似的趋势。
  • 作者认为NLR似乎是ARDS危重患者预后的生物标志物,需前瞻性数据进一步验证。

适用人群与场景

  • 诊断为ARDS并收入ICU的患者。

研究设计与关键结果

  • 研究类型为回顾性队列研究,共纳入224例ICU的ARDS患者,按NLR四分位数分为四组。
  • 四组NLR中位数(四分位距)分别为:第一四分位6.88(4.61-7.94)、第二四分位13.06(11.35-14.89)、第三四分位20.99(19.09-23.19)、第四四分位39.39(32.63-50.15)。
  • 四组28天死亡率分别为10.7%、19.6%、41.4%、53.6%(P<0.001)。
  • 多变量Cox回归显示,以第一四分位为参照,第二四分位调整HR=1.674(95%CI 0.462-6.063,P=0.432),第三四分位调整HR=5.075(95%CI 1.554-16.576,P=0.007),第四四分位调整HR=5.815(95%CI 1.824-18.533,P=0.003)。
  • ICU死亡率和住院死亡率呈现与28天死亡率相似的趋势。

证据类型、等级与局限

  • 证据类型:回顾性队列研究。
  • 局限:作者指出需前瞻性数据进一步验证该关系。

对床旁实践的改变

  • 作者认为NLR似乎是ARDS危重患者预后的生物标志物。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

PURPOSE: Systemic inflammation relates to the initiation and progression of acute respiratory distress syndrome (ARDS). As neutrophil-to-lymphocyte ratio (NLR) has been shown to be a prognostic inflammatory biomarker in various diseases, in this study, we sought to explore whether NLR is a prognostic factor in patients with ARDS.

METHODS: A retrospective study was performed on patients diagnosed as ARDS admitted to the intensive care unit (ICU). We calculated the NLR by dividing the neutrophil count by the lymphocyte count and categorized patients into four groups based on quartile of NLR values. The association of NLR quartiles and 28-day mortality was assessed using multivariable Cox regression. Secondary outcomes included ICU mortality and hospital mortality.

RESULTS: A total of 224 patients were included in the final analysis. The median (interquartile range) NLRs from first quartile to fourth quartile were as follows: 6.88 (4.61-7.94), 13.06 (11.35-14.89), 20.99 (19.09-23.19), and 39.39 (32.63-50.15), respectively. The 28-day mortalities for the same groups were as follows: 10.7%, 19.6%, 41.4%, and 53.6% (P < 0.001). Cox regression analysis showed NLR was a significant risk factor predicting 28-day mortality (first quartile, reference group; second quartile, adjusted hazard ratio [HR]= 1.674, 95% confidence interval [CI], 0.462-6.063, P = 0.432; third quartile, HR = 5.075, 95% CI, 1.554-16.576, P = 0.007; fourth quartile, HR = 5.815, 95% CI, 1.824-18.533, P = 0.003). Similar trends were observed for ICU mortality and hospital mortality.

CONCLUSIONS: High NLR was associated with the poor outcome in critically ill patients with ARDS. The NLR therefore seems to be a prognostic biomarker of outcomes in critically ill patients with ARDS. Further investigation is required to validate this relationship with data collected prospectively.

来源:Shock,查看原文。版权归原作者所有。

参考来源

  1. Li W, Ai X, Ni Y, et al. The Association Between the Neutrophil-to-Lymphocyte Ratio and Mortality in Patients With Acute Respiratory Distress Syndrome: A Retrospective Cohort Study. Shock. 2019. PMID: 29528904. doi:10.1097/SHK.0000000000001136

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。